Venmax Drugs & Pharmaceuticals standalone net profit rises 200.00% in the June 2026 quarter

Sales rise 104.96% to Rs 2.48 crore

Net profit of Venmax Drugs & Pharmaceuticals rose 200.00% to Rs 0.12 crore in the quarter ended June 2026 as against Rs 0.04 crore during the previous quarter ended June 2025. Sales rose 104.96% to Rs 2.48 crore in the quarter ended June 2026 as against Rs 1.21 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2.48	1.21	105
OPM %	4.84	3.31	-
PBDT	0.12	0.04	200
PBT	0.12	0.04	200
NP	0.12	0.04	200

Powered by Capital Market - Live News